Skip to main content

Table 3 Summary of bleeding complications during treatment with immunotherapy

From: Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients

Outcome Not on anticoagulation (n = 828) On anticoagulation (n = 120) p-value
Bleeding outcomesa    0.05
No. (%) 32 (3.9) 10 (8.3)  
95% CIb 2.7–5.4 4.1–14.8  
  1. aBleeding outcomes included major and clinically relevant minor bleeds
  2. b The 95% confidence intervals were calculated using the Clopper-Pearson method